News Category
Quantum BioPharma is progressing its two-pronged approach to neurological health, targeting multiple sclerosis with Lucid-MS and alcohol-related effec...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer highlights the dangers of undercooked pork and the urgent need for imp...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its IP portfolio, strengthenin...
The Keep A Breast Foundation's 2026 High Desert Collection merges art and community to promote breast health awareness, with exhibitions in Pioneertow...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announced completion of manufacturing, regulatory, clinical, and preclinical milestones for its mpox/smallpox vaccine GEO-MVA, supporting initi...
Onco-Innovations is combining PNKP-targeted therapy, nanoparticle delivery, and AI to develop ONC010, aiming to improve cancer treatment efficacy and ...
Nagoya University researchers discovered that the ancient protein C3, when produced by tumor cells, may boost the effectiveness of immunotherapy by ac...
VolitionRx's new Capture-Seq technology, detailed in a peer-reviewed paper, achieves over 99% pure ctDNA isolation, potentially transforming cancer de...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate program into the next development stage and expanded its intellectual property...
The American Heart Association recognizes more than 3,000 health care organizations for their commitment to high-quality cardiovascular care, highligh...
The United States has exceeded its 2025 measles case count, reaching 2,371 cases, the highest in three decades, as outbreaks spread in multiple states...
Oncotelic Therapeutics will showcase its latest clinical progress, including Phase 1b trial advancement and AI-driven platforms, at the OTCQB Virtual ...
Recent independent findings suggest that licensed Ebola vaccines may induce cross-reactive immune responses, supporting broader filovirus vaccine deve...
A new dermatology practice in Trumbull, Connecticut, aims to counter the rushed, impersonal care often found in high-volume clinics by providing compr...
Scientists and public health experts warn that climate change is accelerating the spread of infectious diseases, with implications for global health a...
VERAXA Biotech has promoted antibody therapeutics specialist Dr. Christoph Erkel to Chief Scientific Officer as the company prepares its proprietary B...
Onco-Innovations Limited announced the closing of a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP to fund its ONC...
Dr. Lee Newcomer, a former UnitedHealthcare CMO and health policy expert, has signed with Creative Management Partners agent Alan Morell to promote hi...
A new preclinical study finds that an experimental therapy containing vitamin B12 could stop the progression of glioblastoma multiforme, the deadliest...
VolitionRx announced increasing clinical support for its Nu.Q NETs assay as a biomarker for sepsis, with studies showing its ability to distinguish se...
VERAXA Biotech announced it has filed new patent applications in the first half of 2026, expanding its intellectual property portfolio to over 50 gran...
VERAXA Biotech strengthens its scientific leadership by appointing Dr. Christoph Erkel as Chief Scientific Officer to advance its proprietary BiTAC(R)...
VERAXA Biotech AG has expanded its intellectual property portfolio with new patent filings for its BiTAC-TCE and BiTAC-ADC platforms, strengthening pr...
Dr. Edward H. Davidson, a board-certified plastic surgeon at Palm Beach Plastic Surgery Institute, has been named a 2026 Castle Connolly Top Doctor, a...
A new study aims to understand why some people with cancer risk factors never develop the disease, focusing on the role of autoantibodies in immune re...
Lantern Pharma announced EMA clearance for a Phase 1b/2 trial of LP-184 in advanced bladder cancer, using biomarker-guided patient selection.
The global flow cytometry diagnostics market is projected to grow from $1.5 billion in 2026 to $3.5 billion by 2036, fueled by rising demand for hemat...
GeoVax Labs reports second quarter 2026 financial results and provides business update, highlighting progress toward initiating a pivotal immunobridgi...
Onco-Innovations Limited is progressing its PNKP inhibitor ONC010 through manufacturing scale-up and strategic partnerships, aiming to address cancer ...
New research published in Nature Medicine indicates experimental immunotherapy may provide relief for children with deadly brain and spinal cord tumor...
VERAXA Biotech announced the advancement of its bispecific ADC program VXA-222 after OmniAb completed a key technical milestone, moving the program in...
Onco-Innovations Ltd. is combining a novel DNA repair target, nanoparticle delivery, and AI to address resistance, trial design, and toxicity in oncol...
VERAXA Biotech appointed Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor cancer therapies, succeeding Rick Austin.
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting its development strategy for the lead BiTAC-TCE candida...
Onco-Innovations is developing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the industry shift tow...
UCSF's Dr. Monica Gandhi says recent U.S. outbreaks of measles, mpox, and HIV expose critical gaps in public health systems, while companies like Co-D...
Lantern Pharma announced a U.S. patent allowance for methods using a three-gene biomarker signature to identify patients with ovarian, liver, kidney, ...
VERAXA Biotech AG appointed Christoph Erkel as CSO to advance its proprietary BiTAC platform for solid tumor cancer therapies, succeeding Rick Austin.
iOrganBio appointed Lee L. Rubin, Ph.D., a leading stem cell biologist from Harvard, to its Scientific Advisory Board to advance its AI-powered CellFo...
Quantum BioPharma is advancing a two-pronged approach to brain disorders, focusing on multiple sclerosis with its patented Lucid-MS and on alcohol int...
Oncotelic Therapeutics released peer-reviewed preclinical data for Sapu003, an intravenous everolimus formulation, showing improved pharmacokinetics a...
A new study finds that the ratio of polyunsaturated to monounsaturated fats in the diet could affect immune cell membranes, making them more susceptib...
Kairos Pharma Ltd. has partnered with Bayer to evaluate its antibody ENV-105 in combination with Bayer's XOFIGO for metastatic castration-resistant pr...
VERAXA Biotech AG announced it has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead B...
Greenwich LifeSciences reported progress in its Phase 3 FLAMINGO-01 trial for GLSI-100, including DSMB approval to continue, expanded enrollment to 2,...
Quantum BioPharma is developing Lucid-MS for multiple sclerosis and unbuzzd for alcohol intoxication, addressing significant unmet needs in neurologic...
A comprehensive review commissioned by the World Health Organization found no link between mobile phone use and brain cancer, potentially easing long-...
